Vycor Medical Inc (VYCO):企業の財務・戦略的SWOT分析

◆英語タイトル:Vycor Medical Inc (VYCO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14457
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vycor Medical Inc (Vycor) is a medical device company that develops, designs, and markets medical devices for use in neurosurgery. The company offers computer-based light stimulation therapies for patients suffering from vision loss resulting from neurological trauma such as stroke. It provides sight science neuro-eye therapy, novavision vision restoration therapy, viewsite brain access system, and novavision neuroeyecoach. Vycor offers medical device for neurological brain, spinal and other surgical procedures. Its viewsite brain access system is used by neurosurgeons to access the surgical site in the brain. The company caters neurosurgical and neurotherapeutic solutions to medical community. It has operations in North America and Europe. Vycor is headquartered in Boca Raton, Florida, the US.

Vycor Medical Inc Key Recent Developments

Mar 30,2018: Vycor Medical Announces Financial Results for the Year Ended December 31st, 2017

This comprehensive SWOT profile of Vycor Medical Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Vycor Medical Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Vycor Medical Inc – Key Information
Vycor Medical Inc – Overview
Vycor Medical Inc – Key Employees
Vycor Medical Inc – Key Employee Biographies
Vycor Medical Inc – Key Operational Heads
Vycor Medical Inc – Major Products and Services
Vycor Medical Inc – History
Vycor Medical Inc – Company Statement
Vycor Medical Inc – Locations And Subsidiaries
Vycor Medical Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Vycor Medical Inc – Business Description
Vycor Medical Inc – Corporate Strategy
Vycor Medical Inc – SWOT Analysis
SWOT Analysis – Overview
Vycor Medical Inc – Strengths
Vycor Medical Inc – Weaknesses
Vycor Medical Inc – Opportunities
Vycor Medical Inc – Threats
Vycor Medical Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Vycor Medical Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Vycor Medical Inc, Key Information
Vycor Medical Inc, Key Ratios
Vycor Medical Inc, Share Data
Vycor Medical Inc, Major Products and Services
Vycor Medical Inc, History
Vycor Medical Inc, Key Employees
Vycor Medical Inc, Key Employee Biographies
Vycor Medical Inc, Key Operational Heads
Vycor Medical Inc, Other Locations
Vycor Medical Inc, Subsidiaries
Vycor Medical Inc, Key Manufacturing facilities
Vycor Medical Inc, Key Competitors
Vycor Medical Inc, SWOT Analysis
Vycor Medical Inc, Ratios based on current share price
Vycor Medical Inc, Annual Ratios
Vycor Medical Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Vycor Medical Inc, Performance Chart
Vycor Medical Inc, Ratio Charts

★海外企業調査レポート[Vycor Medical Inc (VYCO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Svevind AB-エネルギー分野:企業M&A・提携分析
    Summary Svevind AB (Svevind) is a renewable energy company that plans, develops and operates land-based wind power projects of different sizes. The company’s services portfolio includes wind project planning, design, sale and electricity generation. Its projects include Gabrielsberget, Hornefors, Gr …
  • Zebra Technologies Corporation:企業の戦略・SWOT・財務情報
    Zebra Technologies Corporation - Strategy, SWOT and Corporate Finance Report Summary Zebra Technologies Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Moximed Inc:医療機器:M&Aディール及び事業提携情報
    Summary Moximed Inc (Moximed), formerly ExploraMed NC4, Inc. focuses to develop unicompartmental load absorber implants for patients with painful knee osteoarthritis (OA). The company provides Atlas Knee System, an implantable knee joint unloader which works as a shock absorber for pre-arthroplasty …
  • Georg Fischer AG:企業の戦略・SWOT・財務情報
    Georg Fischer AG - Strategy, SWOT and Corporate Finance Report Summary Georg Fischer AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Harry Ramsden’s:企業の戦略・SWOT・財務分析
    Harry Ramsden's - Strategy, SWOT and Corporate Finance Report Summary Harry Ramsden's - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • BP Plc (BP.):石油・ガス:M&Aディール及び事業提携情報
    Summary BP Plc (BP) is an integrated oil and gas company. Its upstream activities include exploration, development and production of oil and natural gas, field development and production; and midstream operations include transportation, and marketing and trading of natural gas, including liquefied n …
  • Helix BioPharma Corp (HBP)-製薬・医療分野:企業M&A・提携分析
    Summary Helix BioPharma Corp (Helix) is a biopharmaceutical company with a focus in the field of cancer therapy. The company develops drug candidates for the prevention and treatment of cancer. It develops drugs based on its proprietary technologies. DOS47, the company's proprietary broad anti-cance …
  • Euroclear Plc
    Euroclear Plc - Strategy, SWOT and Corporate Finance Report Summary Euroclear Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Thai Beverage Public Company Limited:戦略・SWOT・企業財務分析
    Thai Beverage Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thai Beverage Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Petro-Victory Energy Corp (VRY):石油・ガス:M&Aディール及び事業提携情報
    Summary Petro-Victory Energy Corp (Petro-Victory) is an oil and gas company that provides exploration and production of hydrocarbon, oil and natural gas resources. The company provides onshore exploration to identify prospective resources, promote and initiate drilling campaigns to find hydrocarbon …
  • Distell Group Limited:戦略・SWOT・企業財務分析
    Distell Group Limited - Strategy, SWOT and Corporate Finance Report Summary Distell Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Owensboro Municipal Utilities:発電所・企業SWOT分析
    Owensboro Municipal Utilities - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Barry Callebaut AG:企業のM&A・事業提携・投資動向
    Barry Callebaut AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Barry Callebaut AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Banque de France:企業の戦略的SWOT分析
    Banque de France - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Linde Malaysia Sdn Bhd:企業の戦略的SWOT分析
    Linde Malaysia Sdn Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Madhya Pradesh Power Generating Company Ltd:企業の発電所・SWOT分析2018
    Madhya Pradesh Power Generating Company Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, info …
  • Ralph Lauren Corp:企業の戦略・SWOT・財務分析
    Ralph Lauren Corp - Strategy, SWOT and Corporate Finance Report Summary Ralph Lauren Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Investec Private Bank (UK & Europe):企業の戦略・SWOT・財務情報
    Investec Private Bank (UK & Europe) - Strategy, SWOT and Corporate Finance Report Summary Investec Private Bank (UK & Europe) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Dexcel PT Israel Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Dexcel PT Israel Ltd (Dexcel Pharma), a subsidiary of Dexcel PT Holdings Ltd, develops, manufactures and markets branded and generic pharmaceuticals. Its featured products include PerioChip (chlorhexidine gluconate), a non-antibiotic adjunct treatment for scaling and root planing and adult p …
  • Helvetia Group:企業の戦略・SWOT・財務情報
    Helvetia Group - Strategy, SWOT and Corporate Finance Report Summary Helvetia Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆